The <scp>NRF2</scp> antagonist <scp>ML385</scp> inhibits <scp>PI3K‐mTOR</scp> signaling and growth of lung squamous cell carcinoma cells
Lili Ji(Nantong University), Ming‐Sound Tsao(University Health Network)
Cited by 45
Related Papers
Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2010|479
PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer
|Annals of Oncology|2017|115
Single-Cell Analysis Reveals Transcriptomic Features of Drug-Tolerant Persisters and Stromal Adaptation in a Patient-Derived EGFR-Mutated Lung Adenocarcinoma Xenograft Model
|Journal of Thoracic Oncology|2022|61
Loss of Phosphatase and Tensin Homolog Protein Expression Is an Independent Poor Prognostic Marker in Lung Adenocarcinoma
|Journal of Thoracic Oncology|2012|56
Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma
|Molecular Cancer|2010|44